Alexza appoints new senior VP and COO
This article was originally published in Scrip
Alexza Pharmaceuticals – which develops treatments for central nervous system conditions including acute repetitive seizures and insomnia – has appointed Peter Schineller senior vice-president and chief commercial officer. Prior to joining Mountain View, California based-Alexza, Mr Schineller served as senior vice-president and general manager at Ventana Medical Systems, a diagnostic company owned by Roche. He will oversee Alexza's global commercialization efforts and strategies for its first approved product Adasuve (Staccatoloxapine) and will report to president and CEO, Thomas King.